–
Nautilus Biotechnology, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.5
FY22:
−63.6
FY23:
−76.2
FY24:
−81.5
FY25:
−66.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−47.7
FY22:
−60.2
FY23:
−70.4
FY24:
−75.1
FY25:
−60.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.3
FY22:
−57.9
FY23:
−63.7
FY24:
−70.8
FY25:
−59.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.3
FY22:
−57.9
FY23:
−63.7
FY24:
−70.8
FY25:
−59.0
All amounts in millions USD